Table 4

 Observed and expected numbers of death in the low and high cumulative exposure groups of 696 acrylamide employees, with a cut-off point of 1 mg/m3 months

Cause of deathBelow 1 mg/m3 monthsOver 1 mg/m3 months
ObsSMR (95% CI)ObsSMR (95% CI)
12 mg/m3 months equal to 1 mg/m3 years.
All causes6286.2 (66.1 to 110.4)7978.9 (62.5 to 98.3)
All malignant neoplasms20104.5 (63.8 to 161.4)2387.7 (55.6 to 131.6)
Digestive organs, peritoneum9198.0 (90.5 to 375.8)8125.3 (54.1 to 246.9)
    Oesophagus0 to (0.0 to 623.8)0 to (0.0 to 494.4)
    Stomach0 to (0.0 to 669.9)1122.5 (3.1 to 682.3)
    Large intestine3197.8 (40.8 to 578.1)4180.4 (49.2 to 461.9)
    Rectum2607.8 (73.5 to 2195.6)0 to (0.0 to 744.9)
    Biliary passages and liver0 to (0.0 to 744.0)1160.7 (4.0 to 895.1)
    Pancreas3319.0 (65.8 to 932.2)2152.7 (18.5 to 551.7)
    All other digestive organs1818.3 (20.5 to 4559.4)0 to (0.0 to 2071.1)
Respiratory system569.5 (22.6 to 162.2)771.2 (28.6 to 146.7)
    Bronchus, trachea, lung572.6 (23.6 to 169.5)774.4 (29.9 to 153.3)
Prostate0 to (0.0 to 360.5)151.5 (1.3 to 286.7)
Kidney0 to (0.0 to 692.8)3434.6 (89.7 to 1270.0)
Bladder or other urinary organs0 to (0.0 to 960.0)1153.5 (3.8 to 855.3)
Central nervous system0 to (0.0 to 569.0)0 to (0.0 to 495.3)
Thyroid and other endocrine glands11625.5 (40.6 to 9057.2)0 to (0.0 to 4760.6)
Lymphatic and haematopoetic3155.2 (32.0 to 453.5)139.7 (1.0 to 221.1)
Non-malignant diseases
    Diabetes mellitus4266.2 (72.6 to 681.7)6305.9 (112.3 to 665.8)
    Cerebrovascular disease272.9 (8.8 to 263.2)361.0 (12.6 to 178.4)
    Heart disease2192.5 (57.3 to 141.4)3391.3 (62.8 to 128.2)
    Non-malignant respiratory disease365.9 (13.6 to 192.5)339.3 (8.1 to 114.7)
    All external causes776.5 (30.7 to 157.6)336.7 (7.6 to 107.1)